Introduction
============

Brucite refers to the neutral layers of magnesium hydroxide, discovered in 1824. The magnesium ion is centered to six octahedrally arranged hydroxide ions. Each hydroxide is bonded to three magnesium atoms.[@b1-ijn-7-4251] Hydrotalcite is derived from the brucite structure, and can be described by the formula, Mg~6~ Al~2~ (CO~3~)(OH)~16~ · 4H~2~O, formed by isomorphous substitution of the Mg^2+^ with Al^3+^ and forming layers with a positive charge. The carbonate anion is the counter-balanced charge of the layers. Layered double hydroxides, ie, hydrotalcite-like materials, take the general formula $\left\lbrack {\text{M}_{1 - \text{x}}^{2 +}\text{M}_{\text{x}}^{3 +}{(\text{OH})}_{2}} \right\rbrack^{x +}\,\left( \text{A}^{\text{m} -} \right)_{x/m} \cdot n\text{H}_{2}\text{O}$, where M^2+^ is a divalent cation, M^3+^ is a trivalent cation, and A^m−^ is an exchangeable anion with charge (m).[@b2-ijn-7-4251],[@b3-ijn-7-4251] Mg/Al-layered double hydroxides have attracted considerable attention as drug delivery materials due to their advantages of easy preparation in the laboratory, good biocompatibility,[@b4-ijn-7-4251] low cytotoxicity,[@b5-ijn-7-4251],[@b6-ijn-7-4251] and full protection of the intercalated drugs.[@b7-ijn-7-4251] Because of these advantages, many pharmaceutically active compounds have been intercalated in order to prolong their action. These include methotrexate,[@b8-ijn-7-4251],[@b9-ijn-7-4251] captopril,[@b10-ijn-7-4251] the anti-inflammatory drugs, fenbufen, diclofenac, ibuprofen, and camptothecin,[@b5-ijn-7-4251],[@b11-ijn-7-4251]--[@b13-ijn-7-4251] as well as the statin agents, pravastatin and fluvastatin.[@b14-ijn-7-4251]

Here we describe our work on the intercalation of perindopril erbumine, an antihypertensive angiotensin-converting enzyme (ACE) inhibitor, into Mg/Al-layered double hydroxide by the ion-exchange technique. Our work was focused on the structure of perindopril between the Mg/Al-layered double hydroxide interlayer, its thermal and controlled release properties, and the effect of the resulting nanocomposite and the Mg/Al-layered double hydroxide on ACE. We compared our results with those reported in the literature for Zn/Al-perindopril.

Materials and methods
=====================

Materials
---------

Perindopril erbumine (C~23~H~43~N~3~O~5~, molecular weight 441.6) of 99.79% purity was purchased from CCM Duopharma (Klang, Malaysia) and used as received. Other materials, including Mg(NO~3~)~2~ · 6H~2~O, Al (NO~3~)~3~ · 9H~2~O, NaOH, ACE, and hippuryl-histidyl-leucine were purchased from Sigma (St Louis, MO) and used as received. Deionized water was used in all experiments.

Synthesis of perindopril erbumine-Mg/Al nanocomposite
-----------------------------------------------------

The precursor, a Mg/Al-layered double hydroxide in nitrate form, was synthesized by a procedure similar to that reported previously.[@b15-ijn-7-4251] A solution of magnesium nitrate 0.025 mol/L and aluminum nitrate 0.0125 mol/L was prepared in deionized water. A solution of sodium hydroxide at a concentration of 2 mol/L was added dropwise to the mother liquor solution with vigorous stirring under a nitrogen atmosphere until a pH of 10 was reached.

Perindopril-Mg/Al-layered double hydroxide was prepared using an ion-exchange method. A fresh layered double hydroxide-NO~3~ precursor was dropped into a 0.3 mol/L solution of perindopril with vigorous stirring in a nitrogen atmosphere. The pH of the mixture was 10.0, and it was kept for 18 hours at 70°C. The precipitate was washed and centrifuged three times. The product was denoted as PMAE.

Controlled-release study
------------------------

Release of perindopril from the PMAE nanocomposite into the medium of phosphate-buffered solution at pH 7.4 and 4.8[@b10-ijn-7-4251],[@b16-ijn-7-4251],[@b17-ijn-7-4251] was performed by adding about 85 mg of PMAE into 250 mL of the buffer solutions. The accumulated amount of perindopril released into the solution was measured at regular intervals using an ultraviolet-visible spectrophotometer at 215 nm. To compare the release rate of perindopril from PMAE with that from the physical mixture of perindopril and pristine Mg/Al-layered double hydroxide (prepared for this purpose),[@b18-ijn-7-4251] 0.6 mg of the physical mixture of perindopril (0.22 mg) and the pristine layered double hydroxide (0.38 mg) was also used to perform the same perindopril release experiments.

MTT cytotoxicity and in vitro antihypertensive assay
----------------------------------------------------

Chang cells from a human liver cells line, were used in this study. The cells were seeded into 96-well plates and kept at 5% CO~2~ and 37°C for 24 hours. When the cells had grown to 90% confluence, they were treated with the perindopril erbumine, PMAE nanocomposite, and Mg/Al-layered double hydroxide formulations at 0.156, 0.313, 0.625, 1.25, 2.5, 5.0, and 10 μg/mL. After 24 hours of incubation, the cells in each well were treated with 20 μL of MTT solution (5 mg/mL) and incubated for 4 hours. The microplates were turned swiftly to discard the medium, and the formazan precipitate was dissolved in 10% sodium dodecyl sulfate in dimethyl sulfoxide containing 0.6% acetic acid. The microplates were then gently shaken in the dark for 30 minutes, and absorbance was measured at 570 nm and 630 nm (background) using a microtiter plate reader. All experiments were carried out in triplicate. The IC~50~ was generated from the dose-response curves for the cells line.

The in vitro antihypertensive activity of free perindopril, intercalated perindopril in layered double hydroxide (ie, PMAE), and Mg/Al-layered double hydroxide was assayed by measuring ACE inhibition activity using the method of Cushman and Cheung (1971). In vitro ACE inhibition activity was quantified by converting hippuryl-histidyl-leucine to hippuric acid via ACE in the presence of the inhibitor; absorbance was measured at 228 nm. Any reduction in absorbance is proportional to the inhibition exerted by the inhibitor being assayed. Perindopril and PMAE (0.5 μg/mL) were preincubated with ACE for 20 minutes in a 25 μL volume in 1 × buffer (pH 8.3), then mixed with 10 μL of 3.5 mM hippuryl-histidyl-leucine. The assay mixture was incubated at 37°C for 30, 60, and 90 minutes. The reaction was stopped by adding 50 μL of 3 mol/L HCl. The hippuric acid formed by ACE was extracted with 1 mL of ethyl acetate. The solvent was removed by heat evaporation and redissolved in deionized water. The amount of hippuric acid was measured using a fluorescent plate reactor at 228 nm.

Characterization
----------------

Powder X-ray diffraction patterns were recorded in the range from 2°--70° on a Shimadzu diffractometer, XRD-6000, using CuK~α~ radiation (λ = 1.5418 Å) at 30 kV and 30 mA, with a dwell time of 0.5 degrees per minute. Fourier transform infrared (FTIR) spectra of the materials were recorded over the range 400--4000 cm^−1^ on a Thermo Nicolet Nexus FTIR (Smart Orbit model) with 4 cm^−1^ resolution, using the KBr disc method with approximately 1% of the sample in 200 mg of spectroscopic grade potassium bromide, and pellets made by pressing at 10 tonnes.

The chemical composition of the samples was analyzed for magnesium and aluminum ions by inductively coupled plasma atomic emission spectrometry using a Perkin-Elmer spectrophotometer model Optima 2000DV (Perkin-Elmer, Boston, MA) under standard conditions. A CHNS-932 LECO instrument was used for carbon, hydrogen, nitrogen, and sulfur analyses. Thermogravimetric and differential thermogravimetric analyses were carried out using a Mettler Toledo instrument with a heating rate of 10°C per minute in the range of 20°C--1000°C under a nitrogen atmosphere (nitrogen flow rate 50 mL per minute). Surface characterization of the material was carried out using a nitrogen gas adsorption-desorption technique at 77 K, with a Micromeritics ASAP 2000 instrument. A field emission scanning electron microscope (Nova^®^ Nanosem 230 model, Hillsboro, OR) was used to determine the surface morphology of the samples. Ultraviolet-visible spectra were measured to determine optical properties, and the controlled release study was accomplished using a Perkin Elmer ultraviolet-visible spectrophotometer (Lambda 35).

Results and discussion
======================

Powder X-ray diffraction
------------------------

Powder X-ray diffraction is a technique used to investigate the phase of crystalline materials present in a sample, which involves interaction between X-rays with crystal to form diffraction patterns, from which much information can be derived. With the help of other methods, such as molecular calculation, the intercalation of anions into the inorganic layered double hydroxide interlayers and their orientation between the interlayers can also be studied.

Powder X-ray diffraction patterns of perindopril erbumine and the product of its reaction with fresh Mg/Al-NO~3~ double hydroxide for the formation of a nanocomposite, PMAE, are shown in [Figure 1A](#f1-ijn-7-4251){ref-type="fig"}. The (00l) reflections of PMAE appeared at a low 2θ angle, ie, 3.86°, 8.66°, and 6.91° for 003, 006, and 009 reflections, respectively. As reported in the literature, 003, 006, and 009 reflections for the precursor Mg/Al-NO~3~ layered double hydroxide appear at 10.71°, 20.45°, and 34.8°, respectively.[@b19-ijn-7-4251] Shifting of the reflection toward low 2θ for PMAE is indicative of intercalation of perindopril into the interlayer galleries of layered double hydroxide by anion exchange with nitrate ions. The (110) at 61.2°, corresponding to 1.53 Å for the Mg/Al-NO~3~ sample, did not shift after the intercalation process, indicating that intercalation of perindopril did not change the structure of the layer, but only changed the interlayer spacing.[@b20-ijn-7-4251] Furthermore, a broad peak at 11.46° corresponds to the (003) reflection of Mg/Al-NO~3~ layered double hydroxide, while this peak is overlapped with the (009) reflection in PMAE. This result indicates the presence of remaining unreacted Mg/Al-NO~3~ layered double hydroxide phase mixed with the intercalated material.

The inset in [Figure 1B and C](#f1-ijn-7-4251){ref-type="fig"} shows the intercalation of perindopril erbumine into Zn/Al-layered double hydroxide accomplished by the ion-exchange method (PZAE) and direct method (PZAC), respectively.[@b21-ijn-7-4251] It can be seen that the d-spacing (d~003~) of the PMAE and PZAE nanocomposites is 22.85 Å and 21.70 Å, respectively. This similarity indicates that the orientation of perindopril between the layers is similar and arranged as an alternating bilayer. The slight discrepancy in the d~003~ value between them is probably mainly due to the content of water in the interlayer galleries and the presence of nitrate ions in the interlayer region.[@b22-ijn-7-4251]

The lattice parameters, *a* and *c*, of PMAE were calculated using d values of 003, 006, and 009 reflections, where *c* = 1/3(3d~003~ + 6d~006~ + 9d~009~), and 110 reflection for parameter *a*, where *a* = 2d~110~, and is shown in [Table 1](#t1-ijn-7-4251){ref-type="table"}. The *a* and *c* values are 3.02 Å and 64.00 Å, respectively.

From [Table 1](#t1-ijn-7-4251){ref-type="table"}, similarity in the *c* value between PMAE and PZAE suggests that the perindopril anions should be arranged in the interlayer space in a similar fashion and that a small difference between them can be related to the conditions of preparation, or more probably the amount of water, as indicated in [Table 1](#t1-ijn-7-4251){ref-type="table"}. The correlation between the M^2+^/Al^3+^ ratio and d~003~ for PMAE and PZAE is in good agreement with that reported previously in the literature.[@b23-ijn-7-4251]

Molecular structure and spatial orientation of intercalated perindopril
-----------------------------------------------------------------------

[Figure 2A](#f2-ijn-7-4251){ref-type="fig"} shows the three-dimensional molecular size of perindopril obtained using Chemoffice software (Cambridge, MA). The long and short axes (the x axis and y axis, respectively) and molecular thickness (z axis) of perindopril were calculated, giving values of 13 Å, 8.4 Å, and 12.6 Å, respectively. The X-ray diffraction pattern shows that the average basal spacing, d, of the PMAE nanocomposite was 21.98 Å (average for five harmonics). The thickness of the Mg/Al-NO~3~ layered double hydroxide layer was 4.8 Å,[@b24-ijn-7-4251] therefore the gallery height of layered double hydroxide after the intercalation processes was 17.18 Å (21.98--4.80 Å). The gallery height of PMAE was 17.18 Å, which is much larger than the value of the long axis (13 Å) and slightly similar to double the short axis (16.80 Å). This indicates that the perindopril anions are accommodated as an alternate bilayer, as illustrated in [Figure 2B](#f2-ijn-7-4251){ref-type="fig"}.

Infrared spectroscopy
---------------------

FTIR is a technique used for identification of functional groups and chemical bonds that are present in a molecule, interpreted from the observed infrared absorption spectrum. Each functional group has its own specific wavenumber/s and absorption characteristics, from which the functional group present in the sample can be inferred. Therefore, this technique can be used as supporting data which complement other techniques to indicate that intercalation instead of adsorption has taken place.

The FTIR spectrum of perindopril erbumine is shown in [Figure 3A](#f3-ijn-7-4251){ref-type="fig"}. As shown in the figure, the band at 2929 cm^−1^ is due to CH in NH--CH-propyl, while the band at 2851 cm^−1^ can be attributed to CH in CH~3~--CH--NH. The band recorded at 1154 cm^−1^ is related to the symmetric stretching of C--N--C.[@b25-ijn-7-4251] The band at 1745 cm^−1^ is due to C═O in the ester group. The carboxylic group shows peaks at 1731 cm^−1^ that are related to nu;(C═O) stretching.

As can be observed in the FTIR spectrum of PMAE ([Figure 3B](#f3-ijn-7-4251){ref-type="fig"}), a broad band at 3452 cm^−1^ could be attributed to OH stretching vibration due to the presence of a hydroxyl group in the layered double hydroxide and/or a physically adsorbed water molecule. A band at 1612 cm^−1^ is due to the asymmetric vibration COO^−^ mode and another band at 1384 cm^−1^ is due to the symmetric vibration of COO^−26^ and also due to co-intercalated nitrate anions which may not be completely removed from the interlayers during the intercalation process. The presence of "new" carboxylate bands confirm that the perindopril species intercalated into the layered double hydroxide layers is in an anionic form. The bands recorded at 1730 cm^−1^ are due to the presence of perindopril adsorbed on the surface in a neutral form. Other bands in the low range of wavenumbers (556 cm^−1^ and 447 cm^−1^) can be ascribed to translational modes of Mg/Al-OH.[@b3-ijn-7-4251],[@b27-ijn-7-4251]

Comparing the FTIR spectra of PMAE with the PZAE and PZAC nanocomposites obtained in our previous work,[@b21-ijn-7-4251] they show no significant difference, indicating that intercalation of perindopril into Mg/Al-layered double hydroxide has taken place without much change in the structure of perindopril in any of the nanocomposites, which is in good agreement with the powder X-ray diffraction results.

Elemental analysis
------------------

Elemental analysis was conducted to determine the organic and inorganic composition of PMAE. As expected, the PMAE nanocomposite contained both organic and inorganic constituents. This indicates that intercalation had occurred, in which perindopril was intercalated into the Mg/Al-layered double hydroxide inorganic interlayers.

The percentage of magnesium and aluminum ions and Mg^2+^/Al^3+^ molar ratio in the PMAE nanocomposite was obtained using the inductively coupled plasma technique, with values of 13.10%, 7.20%, and 2.04%, respectively. As a result of the elemental chemical analysis, the carbon, nitrogen, and perindopril loading between the layers was determined to be 22.46%, 3.46%, and 36.50%, respectively. Loading of perindopril into the Zn/Al systems, namely PZAE and PZAC, was 37.20% and 33.40%, respectively.[@b21-ijn-7-4251] The FTIR spectrum shows a strong band at 1384 cm^−1^ due to the presence of trace amounts of a nitrate group in the interlamellar spacing of layered double hydroxide. Therefore, the empirical formula for the PMAE nanocomposite can be proposed as \[Mg~0.67~Al~0.33~(OH)~2~ \](PE^−^)~0.21~ (NO~3~^−^)~0.12~· 1.4H~2~O.

Thermal analysis
----------------

Thermal analysis is a technique used to measure the percentage of weight loss of a sample as a function of heating temperature, or time under a controlled environment. It is usually used to indicate the decomposition of a sample, from which it relates to thermal stability at selected temperatures, usually between 25°C and 1000°C. In a selected environment, a thermal analysis can also be used to study the oxidation or dehydration behavior of a sample.

The thermal behavior of perindopril erbumine and PMAE was examined using thermogravimetric analysis and differential thermogravimetric analysis ([Figure 4](#f4-ijn-7-4251){ref-type="fig"}). For perindopril erbumine ([Figure 4A](#f4-ijn-7-4251){ref-type="fig"}), two main thermal events were clearly observed. The first one occurred in the region of 90°C--192°C, attributable to melting of perindopril erbumine, corresponding to a sharp peak at 157°C with 24.1% weight loss. The second stage at 192°C--312°C is due to decomposition and subtle combustion of perindopril erbumine,[@b28-ijn-7-4251] corresponding to a strong peak at 276°C with 81.2% weight loss. [Figure 4B](#f4-ijn-7-4251){ref-type="fig"} shows that the thermal decomposition of PMAE progresses through four major stages of weight loss, occurring at temperature maxima of 74°C, 238°C, 357°C, and 669°C with weight losses of 10.0%, 5.2%, 43.2%, and 3.5%, respectively. The first and second stages of weight loss in the range of 28°C--278°C are due to the removal of water physisorbed on the external surface of the layered double hydroxide as well as structured water.[@b29-ijn-7-4251] The third stage of weight loss is usually overlapped[@b30-ijn-7-4251] and can be attributed to dehydroxylation of the metal hydroxide layers and combustion of perindopril anions at 357°C. The final stage of weight loss is related to the formation of spinel phase, MgAl~2~O~4~.[@b31-ijn-7-4251] Increasing the decomposition of perindopril from 276°C (for free perindopril) to 357°C (for perindopril intercalated into the nanocomposite) indicates better thermal stability of perindopril in the intercalated form, PMAE, than the free compound. This presumably is due to electrostatic attraction between the negatively charged functional group of perindopril and the positively charged Mg/Al interlayers.

A similar phenomenon was observed in the case of perindopril intercalated into Zn/Al-layered double hydroxide to form PZAE and PZAC nanocomposites. [Table 2](#t2-ijn-7-4251){ref-type="table"} shows the weight loss percentages for the three types of nanocomposites. The thermal properties of perindopril in these nanocomposites were different, with a maximum temperature corresponding to weight loss in the third stage for PMAE of 357°C, compared with 346°C and 300°C for PZAE and PZAC, respectively. This indicates that the thermal stability of the nanocomposites can be arranged as PMAE \> PZAE \> PZAC.

Surface properties
------------------

[Figure 5A](#f5-ijn-7-4251){ref-type="fig"} shows the adsorption-desorption isotherms for Mg/Al-layered double hydroxide and the PMAE nanocomposite. As shown in the figure, both isotherms are Type IV by International Union of Pure and Applied Chemistry classification, indicating a mesopore-type material.[@b32-ijn-7-4251] The adsorbate uptake of Mg/Al-layered double hydroxide was slow in the relative pressure range of 0.0--0.8, after which rapid adsorption can be observed, with an optimum uptake of about 8 cm^3^/g, indicating a low capacity for uptake of nitrogen gas. However, for the PMAE nanocomposite, adsorbate uptake is slow until relative pressures of 0.4. A further increase of the relative pressure to \>0.4 resulted in rapid adsorption of the absorbent, and reached an optimum at 9.7 cm^3^/g. The desorption branch of the hysteresis loop for Mg/Al-layered double hydroxide was different from that of PMAE. For the former, it shows the H1 type (open-ended cylindrical pore) compared with the H2 type for the latter, PMAE (with open slit-shaped capillaries).[@b33-ijn-7-4251] As a result of nitrogen adsorption, the surface area of the materials was determined by the Brunauer, Emmet, and Teller (BET) method to increase from 3 m^2^/g for Mg/Al-layered double hydroxide to 11 m^2^/g for the PMAE nanocomposite ([Table 3](#t3-ijn-7-4251){ref-type="table"}). This is due to a change in the pore texture as a result of formation of the nanocomposite compound.

[Figure 5B](#f5-ijn-7-4251){ref-type="fig"} shows plots of the Barret-Joyner-Halenda (BJH) desorption pore size distribution for Mg/Al-layered double hydroxide and PMAE. As shown in the figure, a single-peaked pore size distribution is observed for Mg/Al-layered double hydroxide, centered at around 42 Å. On the other hand, the PMAE sample shows a single peak at 112 Å. Due to the intercalation process, the BJH pore volume increased from 0.01 for Mg/Al-layered double hydroxide to 0.02 cm^3^/g for PMAE, whereas the BJH average pore diameter decreased from 108 Å to 40 Å for Mg/Al-layered double hydroxide to PMAE, respectively ([Table 3](#t3-ijn-7-4251){ref-type="table"}).

The inset in [Figure 5A](#f5-ijn-7-4251){ref-type="fig"} shows the adsorption-desorption isotherms for PZAE, PZAC, and Zn/Al-layered double hydroxide.[@b21-ijn-7-4251] The isotherms are Type IV by International Union of Pure and Applied Chemistry classification, similar to those of Mg/Al-layered double hydroxide and PMAE. The desorption branch of the hysteresis loop for Zn/Al-layered double hydroxide, PZAE, and PZAC are different from that of PMAE and Mg/Al-layered double hydroxide, in which the former shows the H3 type (slit-shaped pores). [Table 3](#t3-ijn-7-4251){ref-type="table"} shows the Brunauer, Emmett, and Teller specific surface area for PMAE, Mg/Al-layered double hydroxide, Zn/Al-layered double hydroxide, PZAE, and PZAC. The surface area for PMAE is 11 m^2^/g, which is higher than for PZAE and PZAC, at 2 m^2^/g and 7 m^2^/g, respectively.

The surface morphologies of Mg/Al-layered double hydroxide and PMAE are shown in [Figure 6](#f6-ijn-7-4251){ref-type="fig"}. The micrographs in [Figure 6A and D](#f6-ijn-7-4251){ref-type="fig"} were obtained using a field emission scanning electron microscope at 10,000×, [Figure 6B and E](#f6-ijn-7-4251){ref-type="fig"} at 25,000×, and [Figure 6C and F](#f6-ijn-7-4251){ref-type="fig"} at 50,000× magnifications. [Figure 6A--C](#f6-ijn-7-4251){ref-type="fig"} shows a flake-like porous structure for Mg/Al-layered double hydroxide. However, the morphology changed to a compact nonporous structure ([Figure 6D--F](#f6-ijn-7-4251){ref-type="fig"}) when the PMAE nanocomposite was formed. This morphology is slightly different from that of PZAE, PZAC, and Zn/Al-layered double hydroxide.[@b21-ijn-7-4251]

Sustained-release study
-----------------------

The release properties of perindopril were investigated by adding the intercalated compound into phosphate-buffered solution at pH 7.4 and 4.8. [Figures 7C and D](#f7-ijn-7-4251){ref-type="fig"} show the release profiles of PMAE at pH 4.8 and 7.4, respectively. The inset shows release profiles of a physical mixture of perindopril with Mg/Al-layered double hydroxide into phosphate-buffered solution at 4.8 ([Figure 7A and B](#f7-ijn-7-4251){ref-type="fig"}). The physical mixture shows that the release profile of perindopril is rapid and complete during the initial 10 minutes. This result indicates that the interaction between the contents of the physical mixture is almost negligible. On the other hand, the release rate of perindopril from PMAE was obviously very much lower, indicating that the PMAE nanocomposite could potentially be used as a controlled-release formulation. This may be due to electrostatic attraction between the interlayers of Mg/Al-layered double hydroxide and perindopril anions that were intercalated in between the inorganic interlayers.

The release behavior at pH 4.8 ([Figure 7C](#f7-ijn-7-4251){ref-type="fig"}) was very fast for the first 20 minutes, which can be attributed to partial dissolution of the Mg/Al-layered double hydroxide layer in an acidic environment.[@b34-ijn-7-4251],[@b35-ijn-7-4251] Thereafter, a slower release step characterized by a release percentage of 100% after 1000 minutes can be observed. This slow release step was due to the exchange process between perindopril anions in interlayer and anions in the buffer solution.[@b12-ijn-7-4251],[@b35-ijn-7-4251],[@b36-ijn-7-4251] At pH 7.4, ([Figure 7II](#f7-ijn-7-4251){ref-type="fig"}), the release of perindopril is slower than at pH 4.8, with 100% release by 5000 minutes. The slow and sustained release process may also be due to the ion-exchange process between perindopril and anions in the buffer solution.[@b12-ijn-7-4251],[@b35-ijn-7-4251],[@b36-ijn-7-4251]

The release profiles of PMAE and PZAE (described in our previous work, in which perindopril was intercalated into Zn/Al-layered double hydroxide using the ion-exchange method) were compared.[@b21-ijn-7-4251] The orientation of perindopril in both nanocomposites was bilayered, but the release rate from PMAE was found to be very much lower than that from PZAE. The time taken to complete release was 5000 minutes in the former compared with 70% release within 1000 minutes for the latter at pH 7.4. This is due to the different charge density between the anions and inorganic interlayers. When the charge density was increased, the electrostatic interaction between the layered double hydroxide lattice and interlayer anions was increased, resulting in a slower release rate, as observed in the PMAE sample.

Release kinetics of perindopril from PMAE
-----------------------------------------

The release behavior of perindopril from the PMAE nanocomposite may be described using different kinetic models. The results of kinetic release from perindopril were analyzed using pseudo-first order ([equation 1](#FD1){ref-type="disp-formula"}),[@b37-ijn-7-4251] pseudo-second order ([equation 2](#FD2){ref-type="disp-formula"})[@b38-ijn-7-4251] and parabolic diffusion ([equation 3](#FD3){ref-type="disp-formula"}) models:[@b20-ijn-7-4251] $$\text{ln}\left( {\text{q}_{\text{e}} - \text{q}_{\text{t}}} \right) = \text{ln}\,\text{q}_{\text{e}} - \text{k}_{1}\text{t}$$ $$\text{t}/\text{q}_{\text{t}} = 1/\text{k}_{2}\text{q}_{\text{e}}{}^{2} + \text{t}/\text{q}_{\text{e}}$$ $$\left( {1 - \text{M}_{\text{t}}/\text{M}_{\text{o}}} \right)/\text{t} = \text{k}\,\text{t}^{- 0.5} + \text{b}$$where M~o~ and M~t~ are drug content remaining in the layered double hydroxide at release time 0 and t, respectively, q~e~ and q~t~ are the equilibrium release amount, the release amount at time t, respectively, and k is the corresponding release rate constant.

Using the three kinetic models mentioned above for the kinetic release data, it was found that the pseudo-second order model was more satisfactory compared with other models in this work for describing the release kinetics of perindopril from the PMAE nanocomposite. [Figure 8](#f8-ijn-7-4251){ref-type="fig"} shows plots of the kinetic models at pH 4.8, with a correlation coefficient (R^2^) and k value of 0.9953 and 6.3 × 10^−5^ mg per minute, respectively. At pH 7.4, the corresponding values were 0.9901 and 3.17 × 10^−5^ mg per minute, respectively ([Table 4](#t4-ijn-7-4251){ref-type="table"}). The kinetic results obtained in this work are very similar to a kinetic study of the release of camptothecin from Mg/Al-layered double hydroxide[@b37-ijn-7-4251] and also similar to perindopril erbumine intercalated into Zn/Al-layered double hydroxide by the ion-exchange and coprecipitation methods.[@b21-ijn-7-4251] It is worth mentioning that the release of perindopril from Zn/Al-LDH-intercalated perindopril obtained either by the ion exchange-method (PZAE) or the direct method (PZAC) followed the pseudo-second order model.[@b21-ijn-7-4251]

Cytotoxicity assay and in vitro antihypertensive activity
---------------------------------------------------------

The effect of perindopril erbumine, PMAE, and Mg/Al-layered double hydroxide on cell viability was investigated in this work using a Chang cells line at various concentrations of 0.156, 0.313, 0.625, 1.25, 2.5, 5.0, and 10.0 μg/mL, with 24 hours of incubation time. As shown in [Figure 9](#f9-ijn-7-4251){ref-type="fig"}, perindopril erbumine did not show any effect on the viability of Chang cells. Interestingly, PMAE and Mg/Al-layered double hydroxide also showed no toxic effect on Chang cells, at least up to a concentration of 10.0 μg/mL. These results are consistent with those of a previous study showing no cytotoxicity of Mg/Al-layered double hydroxide on Vero3 cells line.[@b39-ijn-7-4251]

ACE inhibitors are widely used clinically as antihypertensive agents. Perindopril erbumine is a prodrug ester of perindoprilat, an ACE inhibitor. The present study is the first report on the ACE inhibition activity of free Mg/Al-layered double hydroxide versus perindopril erbumine intercalated into Mg/Al. ACE inhibition activity was determined in vitro by monitoring transformation of the hippuryl-histidyl-leucine substrate to hippuric acid. [Figure 10](#f10-ijn-7-4251){ref-type="fig"} and [Table 5](#t5-ijn-7-4251){ref-type="table"} show the effect of perindopril erbumine, PMAE, and Mg/Al-layered double hydroxide on ACE. Mg/Al-layered double hydroxide shows ACE inhibition activity, and a 5.6% decrease in ACE activity was observed at 90 minutes of incubation. Comparing this result with our previous work, Zn/Al-layered double hydroxide did not show any effect on ACE.[@b21-ijn-7-4251] ACE inhibition in the PMAE formulation was time-dependent, that may be attributable to a high level of perindopril erbumine release from the PMAE nanocomposite. However, following incubation of ACE with 0.5 μg/mL of PMAE, ACE inhibition increased from 56.6% to 70.6% at 30 and 90 minutes of incubation, respectively, as compared with the untreated control.

Comparing the inhibitory activity of PMAE with that of PZAE and PZAC nanocomposites, PMAE shows the strongest inhibition of 70.6% after 90 minutes, compared with 70.1% and 55.4% inhibition for PZAE and PZAC, respectively. This is due to the slow release properties as well as the cation effect of magnesium.[@b40-ijn-7-4251]

Conclusion
==========

A new nanocomposite material was synthesized by intercalating perindopril into Mg/Al-layered double hydroxide using a simple ion-exchange method. X-ray diffraction patterns suggested that expansion of interlayer spacing to 21.98 Å is due to the size and spatial orientation of perindopril intercalated into the interlayer, when compared with 21.70 Å and 19.90 Å for PZAE and PZAC, respectively. Interaction between the perindopril moiety and the positive charge of the layered double hydroxide inorganic interlayers was supported by FTIR. Loading of perindopril was estimated to be about 36.5%, 37.2%, and 33.4% (w/w) for PMAE, PZAE, and PZAC, respectively, with more thermal stability than its free counterpart. The thermal stability was in the order of PMAE \> PZAE \> PZAC. Release of perindopril anions into the buffer solution was found to occur in a controlled manner, governed by pseudo-second order kinetics for all the nanocomposites. MTT assay on the Chang cells line show no cytotoxic effect of either Mg/Al-layered double hydroxide or PMAE, similar to the PZAE and PZAC nanocomposites. The Mg/Al-layered double hydroxide showed mild ACE inhibitory activity, but surprisingly, Zn/Al-layered double hydroxide show no effect on ACE. The ACE inhibition activity of PMAE was observed to be time-dependent due to controlled release of perindopril from the interlayers of the nanocomposites. Inhibition by PMAE was higher than for PZAE and PZAC, presumably due to controlled release and the cation effect of magnesium.
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![Powder X-ray diffraction patterns for the nanocomposite, PMAE (**A**). Inset shows the X-ray diffraction patterns for the nanocomposites PZAE (**B**) and PZAC (**C**).[@b21-ijn-7-4251]\
**Abbreviations:** PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/Al by coprecipitation method.](ijn-7-4251f1){#f1-ijn-7-4251}

![Three-dimension structure of perindopril erbumine (**A**) and molecular structural models of perindopril intercalated between interlayers of Mg/Al-LDH (**B**).\
**Abbreviations:** Mg, magnesium; Al, aluminum; LDH, layered double hydroxide.](ijn-7-4251f2){#f2-ijn-7-4251}

![Fourier transform infrared spectra of perindopril erbumine (**A**) and PMAE nanocomposite (**B**). Inset shows the Fourier transform infrared spectra of the nanocomposites PZAE (**C**) and PZAC (**D**).[@b21-ijn-7-4251]\
**Abbreviations:** PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/Al by coprecipitation method.](ijn-7-4251f3){#f3-ijn-7-4251}

![Thermogravimetric and differential thermogravimetric analysis of perindopril (**A**) and PMAE nanocomposite (**B**).\
**Abbreviation:** PMAE, perindopril intercalated into Mg/Al by ion-exchange.](ijn-7-4251f4){#f4-ijn-7-4251}

![Adsorption-desorption isotherms (**A**) and Barret-Joyner-Halenda pore size distributions (**B**) for Mg/Al-LDH and its nanocomposite with perindopril erbumine, PMAE. Inset in (**A**) shows the adsorption-desorption isotherms for PZAE, PZAC, and ZnAl-LDH.[@b21-ijn-7-4251]\
**Abbreviations:** Mg, magnesium; Al, aluminum; LDH, layered double hydroxide; PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/Al by coprecipitation method; Zn, zinc; STP, standard temperature pressure.](ijn-7-4251f5){#f5-ijn-7-4251}

![Field emission scanning electron microscopic images of Mg/Al-LDH (**A**--**C**) and PMAE (**D**--**F**).\
**Abbreviations:** PMAE, perindopril intercalated into Mg/Al by ion-exchange; Mg, magnesium; Al, aluminum; LDH, layered double hydroxide.](ijn-7-4251f6){#f6-ijn-7-4251}

![(**I**) Release profiles of perindopril from the PMAE nanocomposite at pH 4.8 (**C**) and pH 7.4 (**D**) up to 1500 minutes, (**II**) release profiles of perindopril up to 5000 minutes at pH 7.4. Inset shows the release profiles of perindopril from its physical mixture of perindopril with Mg/Al-LDH at pH 4.8 (**A**) and pH 7.4 (**B**).\
**Abbreviations:** PMAE, perindopril intercalated into Mg/Al by ion-exchange; Mg, magnesium; Al, aluminum; LDH, layered double hydroxide.](ijn-7-4251f7){#f7-ijn-7-4251}

![Fitting the data of perindopril release from PMAE at 7.4 (**A**--**C**) and at 4.8 (**D**--**F**).\
**Abbreviation:** PMAE, perindopril intercalated into Mg/Al by ion-exchange.](ijn-7-4251f8){#f8-ijn-7-4251}

![MTT assays of normal Chang liver cells after 24 hours of treatment with perindopril erbumine, PMAE, and Mg/Al-LDH.\
**Abbreviations:** PMAE, perindopril intercalated into Mg/Al by ion-exchange; Mg, magnesium; Al, aluminum; LDH, layered double hydroxide.](ijn-7-4251f9){#f9-ijn-7-4251}

![ACE inhibition (%) for free perindopril and intercalated perindopril, PMAE, PZAE, PZAC, and Mg/Al-LDH at exposure times of 30, 60, and 90 minutes.\
**Abbreviations:** Mg, magnesium; Al, aluminum; LDH, layered double hydroxide; PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/Al by coprecipitation method; Zn, zinc.](ijn-7-4251f10){#f10-ijn-7-4251}

###### 

XRD data of diffraction peaks and the lattice parameters of PMAE, PZAE and PZAC nanocomposites

  **Samples**                                       **d~003~** **(Å)**   **d~006~** **(Å)**   **d~009~** **(Å)**   **d~110~** **(Å)**   ***a*** **(Å)**   ***c*** **(Å)**   **M^2+^/Al^3+^**   ***x***   **Empirical formula**
  ------------------------------------------------- -------------------- -------------------- -------------------- -------------------- ----------------- ----------------- ------------------ --------- -----------------------------------------------------------------------
  PMAE                                              22.83                10.20                6.90                 1.51                 3.02              64.00             2.04               0.33      \[Mg~0.67~AI~0.33~(OH)~2~\](PE^−^)~0.21~(NO~3~^−^)~0.12~·1.4H~2~O
  PZAE[\*](#tfn2-ijn-7-4251){ref-type="table-fn"}   21.70                10.60                7.08                 1.53                 3.07              65.60             3.48               0.22      \[Zn~0.78~AI~0.22~(OH)~2~\](PE^−^)~0.19~(NO~3~^−^)~0.03~·0.4H~2~O
  PZAC[\*](#tfn2-ijn-7-4251){ref-type="table-fn"}   19.90                9.96                 6.67                 1.54                 3.07              59.80             2.60               0.28      \[Zn~0.72~AI~0.28~(OH)~2~\](PE^−^)~0.177~ (NO~3~^−^)~0.103~·0.91H~2~O

**Note:**

Data from reference.[@b21-ijn-7-4251]

**Abbreviations:** Mg, magnesium; Al, aluminum; Zn, zinc; NO~3~, nitrate; PE, perindopril erbumine; OH, hydroxide; PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/Al by coprecipitation method.

###### 

Shows the weight loss percentages for the three types of the nanocomposites; PMAE, PZAE and PZAC

  **Samples**                                       **First weight loss (%)**   **Second weight loss (%)**   **Third weight loss (%)**   **Last weight loss (%)**   **Total weight loss (%)**                                                
  ------------------------------------------------- --------------------------- ---------------------------- --------------------------- -------------------------- --------------------------- ------ ----- ----- ------ ----- ----- ------ ------
  PMAE                                              28                          188                          10.0                        188                        278                         5.2    280   562   43.2   562   725   3.5    61.9
  PZAE[\*](#tfn5-ijn-7-4251){ref-type="table-fn"}   34                          118                          4.2                         119                        258                         13.6   257   487   31.1   591   858   7.0    55.9
  PZAC[\*](#tfn5-ijn-7-4251){ref-type="table-fn"}   38                          137                          6.2                         136                        244                         8.7    246   499   31.8   559   927   12.6   59.3

**Note:**

Data from reference.[@b21-ijn-7-4251]

**Abbreviations:** PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/Al by coprecipitation method.

###### 

Surface properties for the nanomaterials

  **Samples**                                            **BET surface area (m^2^/g)**   **BJH pore volume (cm^3^/g)**   **BJH pore diameter (Å)**
  ------------------------------------------------------ ------------------------------- ------------------------------- ---------------------------
  Mg/Al-LDH                                              3                               0.010                           108
  PMAE                                                   11                              0.020                           40
  Zn/Al-LDH[\*](#tfn7-ijn-7-4251){ref-type="table-fn"}   1                               0.008                           243
  PZAE[\*](#tfn7-ijn-7-4251){ref-type="table-fn"}        2                               0.009                           135
  PZAC[\*](#tfn7-ijn-7-4251){ref-type="table-fn"}        7                               0.025                           157

**Note:**

Data from reference.[@b21-ijn-7-4251]

**Abbreviations:** Zn, zinc; Al, aluminum; Mg, magnesium; LDH, layered double hydroxide; PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/AI by coprecipitation method; BJH, Barret-Joyner-Halenda; BET, Brunauer-Emmett-Teller.

###### 

Correlation coefficient (R^2^), rate constants (K) and half time (t~1/2~) obtained by fitting the perindopril release data from PMAE nanocomposite into solutions at pH 4.8 and 7.4

  **pH**   **Saturation release (%)**   **R^2^**   **Pseudo-second order**                   
  -------- ---------------------------- ---------- ------------------------- -------- ------ -----
  7.4      100                          0.7739     0.7006                    0.9901   3.17   315
  4.8      100                          0.9651     0.9190                    0.9953   6.30   145

**Abbreviation:** PMAE, perindopril intercalated into Mg/Al by ion-exchange.

###### 

ACE activity for perindopril erbumine, PMAE, PZAE, PZAC and Mg/Al-LDH at different exposure times

  **Exposure time (minutes)**   **Perindopril erbumine**   **PMAE**   **MgAl-LDH**   **PZAE[^\*^](#tfn10-ijn-7-4251){ref-type="table-fn"}**   **PZAC[^\*^](#tfn10-ijn-7-4251){ref-type="table-fn"}**
  ----------------------------- -------------------------- ---------- -------------- -------------------------------------------------------- --------------------------------------------------------
  30                            90.8                       56.6       −0.8           43.4                                                     21.5
  60                            93.6                       58.3       1.80           68.2                                                     55.2
  90                            97.3                       70.6       5.60           70.1                                                     55.4

**Note:**

Data obtained from reference.[@b21-ijn-7-4251]

**Abbreviations:** ACE, Angiotensin-converting enzyme; Mg, magnesium; Al, aluminum; LDH, layered double hydroxide; PMAE, perindopril intercalated into Mg/Al by ion-exchange; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/AI by coprecipitation method.
